Triumph Capital Management »

Eledon Pharmaceuticals shares owned by Triumph Capital Management

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Triumph Capital Management from 13F filings

Historical chart of Triumph Capital Management investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Triumph Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Triumph Capital Management

Quarter filed Position value Share count Share price at filing
2026-09-30 $803k 318k 2.53

More positions owned by Triumph Capital Management

Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Victory Portfolios Ii Shs Fr Ca Fl Etf (VFLO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Shor Dur Fix Etf (DFSD)
Ishares Tr Usd Inv Grde Etf (USIG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Innovator Etfs Trust Quity Managd Flr (SFLR)
First Tr Exchange-traded First Tr Enh New (FTSM)
First Tr Exchange Traded Smid Risng Etf (SDVY)
First Tr Exchng Traded Fd Vi Smit Unco Bd Etf (UCON)
Amazon (AMZN)

View all positions for Triumph Capital Management

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Defilade Capital Management
Vanguard Capital Management
Goldman Sachs Group
Ensign Peak Advisors
Geode Capital Management
Catalio Capital Management
Zimmer Partners
Sphera Funds Management
AWM Investment Company
UBS Group
Kingdon Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Eledon Pharmaceuticals